| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/26/2006 | US20060019300 Method for in vitro molecular evolution of protein function |
| 01/26/2006 | US20060019299 using electromagnetic induction and converting a change in mechanical properties before and after bio coupling into electric signals; cantilever |
| 01/26/2006 | US20060019298 Sequencing of modified nucleic acid molecules |
| 01/26/2006 | US20060019297 Expression vector comprising yarrowia regulatory sequences for use in expression of preferential heterologous nucleotide sequences |
| 01/26/2006 | US20060019296 Methods of indentifying modulators of the FGF receptor |
| 01/26/2006 | US20060019295 Genomic barcoding for organism identification |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060019293 Mutations of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 01/26/2006 | US20060019292 Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same |
| 01/26/2006 | US20060019291 Cloning system for construction of recombinant expression vectors |
| 01/26/2006 | US20060019290 Identification of markers in esophageal cancer, colon cancer, head and neck cancer, and melanoma |
| 01/26/2006 | US20060019289 Compositions and methods for gene expression analysis |
| 01/26/2006 | US20060019288 Methods, reaction mixtures, and kits for ligating polynucleotides |
| 01/26/2006 | US20060019287 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/26/2006 | US20060019286 High throughput methods relating to microRNA expression analysis |
| 01/26/2006 | US20060019285 Analysis of intracellular modifications |
| 01/26/2006 | US20060019284 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in lung cancer cells |
| 01/26/2006 | US20060019283 Common marmoset-derived HPRT gene and use thereof |
| 01/26/2006 | US20060019282 Method and unit for detecting an interaction such as hybridization, bioassay plate provided with a number of such detecting units, system for detecting an interaction such as hybridization, and reagent kit |
| 01/26/2006 | US20060019281 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers |
| 01/26/2006 | US20060019280 Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors |
| 01/26/2006 | US20060019279 Methods for target molecule detection using siderophores and related compositions |
| 01/26/2006 | US20060019278 Marker for prenatal diagnosis and monitoring |
| 01/26/2006 | US20060019277 Digital amplification for detection of mismatch repair deficient tumor cells |
| 01/26/2006 | US20060019276 Methods and devices for nucleic acid sequence determination |
| 01/26/2006 | US20060019275 Nucleic acids encoding proteins involved in sensory transduction |
| 01/26/2006 | US20060019274 Nano-PCR: methods and devices for nucleic acid amplification and detection |
| 01/26/2006 | US20060019273 Detection card for analyzing a sample for a target nucleic acid molecule, and uses thereof |
| 01/26/2006 | US20060019272 Diagnosis of disease and monitoring of therapy using gene expression analysis of peripheral blood cells |
| 01/26/2006 | US20060019271 Submergence-induced protein-like factors |
| 01/26/2006 | US20060019270 Global DNA methylation assessment using bisulfite PCR |
| 01/26/2006 | US20060019269 Peripheral arterial occlusive disease (PAOD); prophylaxis of myocardial infarction by administering an agent that inhibits leukotriene synthesis in vivo for example (R)-(+)-alpha-cyclopentyl-4-(2-quinolinylmethoxy)-Benzeneacetic acid, BAY-X-1005; coadministering a statin |
| 01/26/2006 | US20060019268 Molecular markers of cisplatin resistance in cancer and uses thereof |
| 01/26/2006 | US20060019267 Methods and kits for analyzing polynucleotide sequences |
| 01/26/2006 | US20060019266 Novel nucleotide mixture for improved nucleic acid amplification performance |
| 01/26/2006 | US20060019265 Transmission-based luminescent detection systems |
| 01/26/2006 | US20060019264 Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| 01/26/2006 | US20060019263 Sequencing preferential nucleotide sequences using solid support comprised of polydimethylsiloxane-polyethylene glycol grafted layers and a polyelectrolyte multilayer linked to polynucleotide template; high throughput assay |
| 01/26/2006 | US20060019262 Activation induced deaminase (AID) |
| 01/26/2006 | US20060019261 RNA-binding protein |
| 01/26/2006 | US20060019260 Method for tapping the immunological repertoire |
| 01/26/2006 | US20060019259 Characterization of biopolymers by resonance tunneling and fluorescence quenching |
| 01/26/2006 | US20060019258 Methods and compositions for detection of small interfering RNA and micro-RNA |
| 01/26/2006 | US20060019257 Compositions and methods for increasing protein production |
| 01/26/2006 | US20060019256 Compositions and methods for treating and diagnosing cancer |
| 01/26/2006 | US20060019255 Nucleotide sequences specific to brucella and methods for the detection of brucella |
| 01/26/2006 | US20060019254 Nucleotide sequences specific to Yersinia pestis and methods for the detection of Yersinia pestis |
| 01/26/2006 | US20060019253 Polymerase chain reaction analysis by mixing a dsDNA binding dye with a sample of target nucleic acid and primers configured for amplifying; melting the amplified target nucleic acid to generate a melting curve; plotting; repeating; comparison; melting curve difference for each target nucleic acid |
| 01/26/2006 | US20060019252 Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 01/26/2006 | US20060019251 Method for the qualitative and quantitative determination of genetic material |
| 01/26/2006 | US20060019250 Method for the detection of carcinoembryonic agent and cancer diagnosis method based thereon |
| 01/26/2006 | US20060019249 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor-and non-tumor cells |
| 01/26/2006 | US20060019248 mutant SH3-binding protein (SH3BP2) nucleic acids, polypeptides, and agents which selectively bind to the mutant SH3BP2 molecules and which do not bind to the wild type SH3BP2 molecules |
| 01/26/2006 | US20060019247 Detecting the labeled nucleic acid synthesized from the template after passing through a nanoporous separatorcompiling a nucleotide distance map for each type of labeled nucleotide to determine its sequence |
| 01/26/2006 | US20060019246 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases |
| 01/26/2006 | US20060019245 HCV variants |
| 01/26/2006 | US20060019244 Sensor element comprising recognition ligands bound to a film on a single mode planar optical waveguide, film consisting of a membrane, a polymerized bilayer membrane, and a self-assembled monolayer containing polyethylene glycol or polypropylene glycol groups therein; detecting and quantifying proteins |
| 01/26/2006 | US20060019243 Method and device for mixing samples on a support |
| 01/26/2006 | US20060019242 Detection of herpes simplex virus |
| 01/26/2006 | US20060019241 Na+ and CI-coupled transport system for endogenous opioid peptides |
| 01/26/2006 | US20060019240 Posh nucleic acids, polypeptides and related methods |
| 01/26/2006 | US20060019239 enhancing the immunogenicity of a vaccine against Bacillus anthracis by administering an oligodeoxynucleotide with a vaccine against Bacillus anthracis; Anthrax Vaccine Adsorbed (AVA) vaccine |
| 01/26/2006 | US20060019238 Method for identifying protein-protein interactions |
| 01/26/2006 | US20060019237 In vitro wound healing assay and device |
| 01/26/2006 | US20060019236 Membrane fusion assay |
| 01/26/2006 | US20060019235 Molecular and functional profiling using a cellular microarray |
| 01/26/2006 | US20060018930 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/26/2006 | US20060018927 Major nucleocapsid protein/phosphoprotein, large polymerase protein, a M2 (ORF1) RNA polymerase elongation factor, and RSV genome/antigenome of human strains; point mutations; glycoproteins; immunogens |
| 01/26/2006 | US20060018924 Recombinantly produced, enzymatically active, includes two amino acid motifs |
| 01/26/2006 | US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| 01/26/2006 | US20060018917 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 01/26/2006 | US20060018916 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 01/26/2006 | US20060018915 Heteroclitic analogs and related methods |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/26/2006 | US20060018893 Method for determining modulation of P110delta activity |
| 01/26/2006 | US20060018889 Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy |
| 01/26/2006 | US20060018871 aptamer PEG conjugate; transplant rejection; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 01/26/2006 | US20060018826 Biologic modulations with nanoparticles |
| 01/26/2006 | DE102005021001A1 Bildbasiertes Verfahren zum Detektieren und Entfernen von kleinen Fragmenten in segmentierten dreidimensionalen Volumina Image-based method for detecting and removing small fragments in segmented three-dimensional volumes |
| 01/26/2006 | DE102004032216A1 Polypeptide mit Tannase- und/oder Lipase-Aktivität Polypeptides with Tannase- and / or lipase activity |
| 01/26/2006 | DE10142743B4 Biochips mit Dimorphismus-spezifischen Faktoren aus Candida albicans Biochips with dimorphism-specific factors of Candida albicans |
| 01/26/2006 | CA2575404A1 Active substances for increasing pathogenic defence in plants and methods for the detection thereof |
| 01/26/2006 | CA2574447A1 Housekeeping genes and methods for identifying the same |
| 01/26/2006 | CA2574311A1 Method of predicting the responsiveness oa a tumor to erbb receptor drugs |
| 01/26/2006 | CA2574179A1 Detection of cellular stress |
| 01/26/2006 | CA2574177A1 Lrp4/corin dopaminergic neuron progenitor cell markers |
| 01/26/2006 | CA2574165A1 Esr1 and cervical cancer |
| 01/26/2006 | CA2574146A1 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| 01/26/2006 | CA2574014A1 Method for detecting the risk of and for treatment of type 2 diabetes |
| 01/26/2006 | CA2573945A1 Single nucleotide polymorphisms as prognostic tool to diagnose adverse drug reactions (adr) and drug efficacy |
| 01/26/2006 | CA2573779A1 Cardiovascular prognostic and diagnostic marker |
| 01/26/2006 | CA2573357A1 Methods and assays for detecting guanylate cyclase activity |
| 01/26/2006 | CA2571763A1 Fluorescence assay for mtp activity |
| 01/26/2006 | CA2571250A1 Galnts as modifiers of the igfr pathway and methods of use |
| 01/26/2006 | CA2570975A1 Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays |
| 01/26/2006 | CA2570602A1 Agents for regulating the activity of interferon-producing cells |
| 01/26/2006 | CA2568012A1 Cdk9 as modifier of the igf pathway and methods of use |
| 01/26/2006 | CA2567980A1 Acacs as modifiers of the igf pathway and methods of use |
| 01/26/2006 | CA2566914A1 Liver disease-related methods and systems |
| 01/25/2006 | EP1619504A1 Novel use of the kinases RSK4 and PAK5 |